Skip to main content
Top
Published in: World Journal of Pediatrics 1/2021

01-02-2021 | Constipation | Original Article

Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial

Authors: Sahar M. A. Hassanein, Shaymaa M. Deifallah, Hend A. Bastawy

Published in: World Journal of Pediatrics | Issue 1/2021

Login to get access

Abstract

Background

Constipation is a common problem in children with spastic cerebral palsy (sCP) with a prevalence that reaches 75%. We hypothesized that treating constipation in those children will improve their health and shorten time spent in daily care. Our aim was to evaluate the efficacy and safety of oral magnesium sulfate for treating chronic constipation in children with sCP.

Methods

A prospective, double-blinded randomized control trial was carried out involving 100 children aged 2–12 years with sCP (level III–V of the Gross Motor Functional Classification system) and chronic constipation. They were followed up in the Pediatric neurology clinic, Children’s hospital, Ain Shams University, May 2017- January 2019. The intervention group (O–Mg) received oral magnesium sulfate 1 mL/kg/day daily for 1 month compared to the placebo. Outcome measures were constipation improvement and decrease in bowel evacuation time after 1 month.

Results

Initially, weekly bowel movements, constipation scores and stool consistency were comparable in both groups. After 1 month of regular administration of oral magnesium sulfate, the constipation score, stool frequency and consistency improved compared to the placebo group (P < 0.001). Effective safe treatment was achieved in 31 (68%) and 4 (9.5%) patients in the O–Mg and placebo groups, respectively (RR, 2.95; 95% CI 2.0–4.5) (P < 0.001). Painful bowel evacuation attempts spent by mothers decreased from 25 (55.6%) of the cases initially to 10 (22%) cases after one month in the O–Mg group (P = 0.001). In contrast, in the placebo group, the decrease went from 21 (50%) cases initially to 18 (42.9%) after 1 month and was not significant (P = 0.5).

Conclusions

Oral magnesium sulfate seems effective in alleviating chronic constipation and pain experience in children with sCP. Consequently, saving maternal time spent in daily bowel evacuation attempts.
Literature
1.
go back to reference Abas O, Abdelaziem F, Kilany A. Clinical spectrum of cerebral palsy and associated disability in south egypt: a local survey study. Open Access Maced J Med Sci. 2017;5:37–41.CrossRef Abas O, Abdelaziem F, Kilany A. Clinical spectrum of cerebral palsy and associated disability in south egypt: a local survey study. Open Access Maced J Med Sci. 2017;5:37–41.CrossRef
2.
go back to reference El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Metwally NA, Badry R, et al. Cerebral palsy in Al-Quseir City, Egypt: prevalence, subtypes, and risk factors. Neuropsychiatr Dis Treat. 2014;10:1267–72.PubMedPubMedCentral El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Metwally NA, Badry R, et al. Cerebral palsy in Al-Quseir City, Egypt: prevalence, subtypes, and risk factors. Neuropsychiatr Dis Treat. 2014;10:1267–72.PubMedPubMedCentral
3.
go back to reference Hassanein SM, Deifalla SM, El-Houssinie M, Mokbel SA. Safety and efficacy of cerebrolysin in infants with communication defects due to severe perinatal brain insult: a randomized controlled clinical trial. J ClinNeurol. 2016;12:79–84. Hassanein SM, Deifalla SM, El-Houssinie M, Mokbel SA. Safety and efficacy of cerebrolysin in infants with communication defects due to severe perinatal brain insult: a randomized controlled clinical trial. J ClinNeurol. 2016;12:79–84.
4.
go back to reference Bhatia M, Joseph B. Rehabilitation of cerebral palsy in a developing country: the need for comprehensive assessment. Pediatr Rehabil. 2000;4:83–6.PubMed Bhatia M, Joseph B. Rehabilitation of cerebral palsy in a developing country: the need for comprehensive assessment. Pediatr Rehabil. 2000;4:83–6.PubMed
5.
go back to reference Veugelers R, Benninga MA, Calis EA, Willemsen SP, Evenhuis H, Tibboel D, et al. Prevalence and clinical presentation of constipation in children with severe generalized cerebral palsy. Dev Med Child Neurol. 2010;52:e216–21.CrossRef Veugelers R, Benninga MA, Calis EA, Willemsen SP, Evenhuis H, Tibboel D, et al. Prevalence and clinical presentation of constipation in children with severe generalized cerebral palsy. Dev Med Child Neurol. 2010;52:e216–21.CrossRef
6.
go back to reference Ferreira A, Mayer MPA, Kawamoto D, Santos M. Constipation, antiepileptic drugs, and gingivitis in children and adolescents with cerebral palsy. Int J Paediatr Dent. 2019;29:635–41.CrossRef Ferreira A, Mayer MPA, Kawamoto D, Santos M. Constipation, antiepileptic drugs, and gingivitis in children and adolescents with cerebral palsy. Int J Paediatr Dent. 2019;29:635–41.CrossRef
7.
go back to reference Park ES, Park CI, Cho SR, Na SI, Cho YS. Colonic transit time and constipation in children with spastic cerebral palsy. Arch Phys Med Rehabil. 2004;85:453–6.CrossRef Park ES, Park CI, Cho SR, Na SI, Cho YS. Colonic transit time and constipation in children with spastic cerebral palsy. Arch Phys Med Rehabil. 2004;85:453–6.CrossRef
8.
go back to reference Hyams J, Colletti R, Faure C, Gabriel-Martinez E, Maffei HV, Morais MB, et al. Functional gastrointestinal disorders: working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2002;35(Suppl 2):S110–7.CrossRef Hyams J, Colletti R, Faure C, Gabriel-Martinez E, Maffei HV, Morais MB, et al. Functional gastrointestinal disorders: working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2002;35(Suppl 2):S110–7.CrossRef
9.
go back to reference Kokkonen J, Haapalahti M, Tikkanen S, Karttunen R, Savilahti E. Gastrointestinal complaints and diagnosis in children: a population-based study. Acta Paediatr. 2004;93:880–6.CrossRef Kokkonen J, Haapalahti M, Tikkanen S, Karttunen R, Savilahti E. Gastrointestinal complaints and diagnosis in children: a population-based study. Acta Paediatr. 2004;93:880–6.CrossRef
10.
go back to reference Rivi E, Filippi M, Fornasari E, Mascia MT, Ferrari A, Costi S. Effectiveness of standing frame on constipation in children with cerebral palsy: a single-subject study. OccupTherInt. 2014;21:115–23. Rivi E, Filippi M, Fornasari E, Mascia MT, Ferrari A, Costi S. Effectiveness of standing frame on constipation in children with cerebral palsy: a single-subject study. OccupTherInt. 2014;21:115–23.
11.
go back to reference Rossier P, van Erven S, Wade DT. The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis. Eur J Neurol. 2000;7:741–4.CrossRef Rossier P, van Erven S, Wade DT. The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis. Eur J Neurol. 2000;7:741–4.CrossRef
12.
go back to reference Chen HY, Cheng FC, Pan HC, Hsu JC, Wang MF. Magnesium enhances exercise performance via increasing glucose availability in the blood, muscle, and brain during exercise. PLoS ONE. 2014;9:e85486.CrossRef Chen HY, Cheng FC, Pan HC, Hsu JC, Wang MF. Magnesium enhances exercise performance via increasing glucose availability in the blood, muscle, and brain during exercise. PLoS ONE. 2014;9:e85486.CrossRef
13.
go back to reference Sun Q, Weinger JG, Mao F, Liu G. Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration. Neuropharmacology. 2016;108:426–39.CrossRef Sun Q, Weinger JG, Mao F, Liu G. Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration. Neuropharmacology. 2016;108:426–39.CrossRef
14.
go back to reference Na HS, Lee JH, Hwang JY, Ryu JH, Han SH, Jeon YT, et al. Effects of magnesium sulphate on intraoperative neuromuscular blocking agent requirements and postoperative analgesia in children with cerebral palsy. Br J Anaesth. 2010;104:344–50.CrossRef Na HS, Lee JH, Hwang JY, Ryu JH, Han SH, Jeon YT, et al. Effects of magnesium sulphate on intraoperative neuromuscular blocking agent requirements and postoperative analgesia in children with cerebral palsy. Br J Anaesth. 2010;104:344–50.CrossRef
15.
go back to reference Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936–71.CrossRef Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936–71.CrossRef
16.
go back to reference Tanaka K, Miyake Y, Sasaki S, Ohya Y, Miyamoto S, Matsunaga I, et al. Magnesium intake is inversely associated with the prevalence of tooth loss in Japanese pregnant women: the Osaka Maternal and Child Health Study. Magnes Res. 2006;19:268–75.PubMed Tanaka K, Miyake Y, Sasaki S, Ohya Y, Miyamoto S, Matsunaga I, et al. Magnesium intake is inversely associated with the prevalence of tooth loss in Japanese pregnant women: the Osaka Maternal and Child Health Study. Magnes Res. 2006;19:268–75.PubMed
17.
go back to reference Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58:258–74.CrossRef Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58:258–74.CrossRef
18.
go back to reference Institute of Medicine (US) Standing committee on the scientific evaluation of dietary reference intakes. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and Fluoride. Washington (DC): National Academies Press (US); 1997. PMID: 23115811. Institute of Medicine (US) Standing committee on the scientific evaluation of dietary reference intakes. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and Fluoride. Washington (DC): National Academies Press (US); 1997. PMID: 23115811. 
19.
go back to reference Dupont C, Campagne A, Constant F. Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation. Clin Gastroenterol Hepatol. 2014;2:1280–7.CrossRef Dupont C, Campagne A, Constant F. Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation. Clin Gastroenterol Hepatol. 2014;2:1280–7.CrossRef
20.
go back to reference Mori H, Suzuki H, Hirai Y, Okuzawa A, Kayashima A, Kubosawa Y, et al. Clinical features of hypermagnesemia in patients with functional constipation taking daily magnesium oxide. J Clin Biochem Nutr. 2019;65:76–81.CrossRef Mori H, Suzuki H, Hirai Y, Okuzawa A, Kayashima A, Kubosawa Y, et al. Clinical features of hypermagnesemia in patients with functional constipation taking daily magnesium oxide. J Clin Biochem Nutr. 2019;65:76–81.CrossRef
21.
go back to reference Tatsuki M, Miyazawa R, Tomomasa T, Ishige T, Nakazawa T, Arakawa H. Serum magnesium concentration in children with functional constipation treated with magnesium oxide. World J Gastroenterol. 2011;17:779–83.CrossRef Tatsuki M, Miyazawa R, Tomomasa T, Ishige T, Nakazawa T, Arakawa H. Serum magnesium concentration in children with functional constipation treated with magnesium oxide. World J Gastroenterol. 2011;17:779–83.CrossRef
22.
go back to reference Bothe G, Coh A, Auinger A. Efficacy and safety of a natural mineral water rich in magnesium and sulphate for bowel function: a double-blind, randomized, placebo-controlled study. Eur J Nutr. 2017;56:491–9.CrossRef Bothe G, Coh A, Auinger A. Efficacy and safety of a natural mineral water rich in magnesium and sulphate for bowel function: a double-blind, randomized, placebo-controlled study. Eur J Nutr. 2017;56:491–9.CrossRef
23.
go back to reference Vu MK, Nouwens MA, Biemond I, Lamers CB, Masclee AA. The osmotic laxative magnesium sulphate activates the ileal brake. Aliment Pharmacol Ther. 2000;14:587–95.CrossRef Vu MK, Nouwens MA, Biemond I, Lamers CB, Masclee AA. The osmotic laxative magnesium sulphate activates the ileal brake. Aliment Pharmacol Ther. 2000;14:587–95.CrossRef
24.
go back to reference Steiner SA, Torres MR, Penna FJ, Gazzinelli BF, Corradi CG, Costa AS, et al. Chronic functional constipation in children: adherence and factors associated with drug treatment. J Pediatr Gastroenterol Nutr. 2014;58:598–602.CrossRef Steiner SA, Torres MR, Penna FJ, Gazzinelli BF, Corradi CG, Costa AS, et al. Chronic functional constipation in children: adherence and factors associated with drug treatment. J Pediatr Gastroenterol Nutr. 2014;58:598–602.CrossRef
25.
go back to reference Koppen IJN, van Wassenaer EA, Barendsen RW, Brand PL, Benninga MA. Adherence to polyethylene glycol treatment in children with functional constipation is associated with parental illness perceptions, satisfaction with treatment, and perceived treatment convenience. J Pediatr. 2018;199:e1.CrossRef Koppen IJN, van Wassenaer EA, Barendsen RW, Brand PL, Benninga MA. Adherence to polyethylene glycol treatment in children with functional constipation is associated with parental illness perceptions, satisfaction with treatment, and perceived treatment convenience. J Pediatr. 2018;199:e1.CrossRef
26.
go back to reference Imanieh MH, Golpayegan MR, Sedighi M, Ahmadi K, Aghaie A, Dehghani SM, et al. Comparison of three therapeutic interventions for chronic constipation in paediatric patients with cerebral palsy: a randomised clinical trial. Prz Gastroenterol. 2019;14:292–7.PubMedPubMedCentral Imanieh MH, Golpayegan MR, Sedighi M, Ahmadi K, Aghaie A, Dehghani SM, et al. Comparison of three therapeutic interventions for chronic constipation in paediatric patients with cerebral palsy: a randomised clinical trial. Prz Gastroenterol. 2019;14:292–7.PubMedPubMedCentral
27.
go back to reference Faleiros-Castro FS, de Paula ED. Constipation in patients with quadriplegic cerebral palsy: intestinal reeducation using massage and a laxative diet. Rev Esc Enferm USP. 2013;47:836–42.CrossRef Faleiros-Castro FS, de Paula ED. Constipation in patients with quadriplegic cerebral palsy: intestinal reeducation using massage and a laxative diet. Rev Esc Enferm USP. 2013;47:836–42.CrossRef
28.
go back to reference Sawyer MG, Bittman M, Lag AM, Crettenden AD, Borojevic N, Raghavendra P, et al. Time demands of caring for children with cerebral palsy: what are the implications for maternal mental health? Dev Med Child Neurol. 2011;53:338–43.CrossRef Sawyer MG, Bittman M, Lag AM, Crettenden AD, Borojevic N, Raghavendra P, et al. Time demands of caring for children with cerebral palsy: what are the implications for maternal mental health? Dev Med Child Neurol. 2011;53:338–43.CrossRef
Metadata
Title
Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial
Authors
Sahar M. A. Hassanein
Shaymaa M. Deifallah
Hend A. Bastawy
Publication date
01-02-2021
Publisher
Springer Singapore
Published in
World Journal of Pediatrics / Issue 1/2021
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-020-00401-0

Other articles of this Issue 1/2021

World Journal of Pediatrics 1/2021 Go to the issue